The Director, Pain, Global Value & Access Strategy role will serve as Market Access Lead for the chronic indications (DPN/LSR/PNP) across our Pain portfolio, with a specific focus on suzetrigine. Based on positive Phase 2 data, Vertex is advancing into pivotal development in diabetic peripheral neuropathy (DPN) and lumbosacral radiculopathy, or LSR, which is pain caused by impairment or injury to nerve roots in the area of the lumbar spine. The individual will be responsible for leading the development of Global Market Access strategies, as well as co-lead the Global Commercial Team across the Vertex Pain portfolio. The role reports to Sr. Director, Pain Portfolio lead.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
5,001-10,000 employees